Healthcare & Life Sciences

Healthcare industry regulations, life sciences developments, pharmaceutical compliance, and medical device approvals.

China’s 2025 Open Door Pilots: Unlocking Telecom, Health, Education FDI

By /

Unlocking China: An Investor’s Guide to Telecom, Healthcare & Education Pilot Programs Estimated reading time: 9 minutes Key Takeaways China’s new “Open Door Pilot Programs” are strategically liberalizing previously restricted sectors—telecommunications, healthcare, and education—for foreign direct investment, signaling a significant shift within the State Council’s 2025 Action Plan. Key reforms include full foreign ownership for […]

China’s 2025 Open Door Pilots: Unlocking Telecom, Health, Education FDI Read More »

China’s Anti-Corruption Storm 2025: Navigating Healthcare Enforcement

By /

China’s Anti-Corruption Storm: Navigating 2025 Enforcement in Healthcare and Beyond Estimated reading time: 8 minutes Key Takeaways China’s anti-corruption campaign is intensifying through 2025, sweeping the healthcare industry with over 52,000 cases filed, 40,000 individuals punished, and 2,600 referred for prosecution, impacting senior officials, hospital executives, and pharmaceutical leaders. New SAMR guidelines (January 2025) target

China’s Anti-Corruption Storm 2025: Navigating Healthcare Enforcement Read More »